Doctors could be a step closer to finding the most effective way to treat cancer with a double whammy of a virus combined with boosting the natural immune system, according to a pioneering study by researchers at The University of Texas Health Science Center at Houston (UTHealth) and The Ohio State University.
“The findings of this research are very exciting because it helps unravel the complex yin and yang relationship between the natural cancer-fighting power intrinsic to our immune system and externally added cancer-killing cells that are given as a therapy. It’s very significant because it shows, contrary to recent scientific claims, that virotherapy can be combined with cell therapy for a positive effect,” said the study’s corresponding author Balveen Kaur, Ph.D., professor and vice chair of research in the Vivian L. Smith Department of Neurosurgery at McGovern Medical School at UTHealth.
Previous scientific wisdom has discredited combining virotherapy and externally added NK cell therapy to the body’s natural killer (NK) cells, but there could be clear cancer-fighting benefits – providing enough external NK cells are deployed to destroy the tumor and stop its spread, as revealed in the paper published this week in Proceedings of the National Academy of Sciences of the United States of America (PNAS).
To reach this conclusion, physicians devised a mathematical formula unlocking the complex interactive relationship between externally introduced viruses and NK cells in addition to the immune system’s existing NK cells to calculate cancer cell-killing potency. The mathematical modeling was able to predict how a virus-treated tumor would respond to NK cell therapy, depending on the number of NK cells introduced to the tumor. It showed that when the number of externally introduced NK cells is increased, the ability to fight cancer is strengthened. While the patient’s own NK cells, present in smaller numbers, concentrate on clearing the virus and therefore have an adverse effect on virotherapy by limiting the virus’s cancer-busting power, this impact can be reversed to destroy more of the tumor by introducing greater numbers of external NK cells. The theory behind these equations was subsequently confirmed in practice by experiments on mice with brain tumors, paving the way for further work.
NK cells are an essential part of the innate immune system and they play a critical role in protecting the body from cancer. The primary function of NK cells is to fight infections, which means they attack the introduced virus, thus thwarting its therapeutic capacity. However, if sufficient numbers of extra NK cells are added, they can kill more tumor cells directly and compensate for this negative influence.
“Natural NK cells sense and kill infected cancer cells, thus clearing viruses. But by adding exogenous NK cells in sufficient quantities, they can also destroy the residual tumor. Our tests showed when you get this ratio right, there’s a significant improvement in cancer-fighting efficacy,” said Kaur, who is a member of The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences. “So it’s a big step forward, which should create more opportunities for further research and development of clinical trials for the treatment of cancer in humans and animals.”
The Latest on: Cancer treatment
via Google News
The Latest on: Cancer treatment
- Brother and sister told they had cancer on the same date a year apart both given the all-clearon April 17, 2021 at 5:48 pm
A BROTHER and sister told they had cancer on the same date a year apart have both been given the all-clear. Usually inseparable Marley and Harmony Young were forced apart for treatment due to the ...
- DUSP16 promotes cancer chemoresistance through regulation of mitochondria-mediated cell deathon April 16, 2021 at 10:12 am
Chemoresistance is one of the main challenges for cancer therapy success. Here, the authors show that dual-specificity phosphatase 16 (DUSP16) expression is associated with chemoresistance in several ...
- FDA approves immunotherapy for first-line treatment of advanced gastric canceron April 16, 2021 at 10:04 am
Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric ...
- Researchers explain the toxicity of USP7 inhibitors, under development for cancer treatmenton April 16, 2021 at 7:43 am
Understanding the components that control cell division is fundamental to understanding how life works and how alterations in this delicate process can cause diseases such as cancer. It was precisely ...
- Breast cancer treatment can be safely reduced in women over the age of 70on April 15, 2021 at 10:23 pm
Oncologists faced with treating older women with breast cancer often must decide if the treatment may be more detrimental than the cancer.
- Cell therapy treatment offers hope to blood cancer patientson April 15, 2021 at 2:56 pm
A new type of cancer treatment could be a game-changer for patients with multiple myeloma, the second most common type of blood cancer that is diagnosed in about 35,000 people in the U.S. each year.
- New research shows breast cancer treatment in patients over age 70 can be safely reducedon April 15, 2021 at 9:43 am
Oncologists faced with treating older women with breast cancer often must decide if the treatment may be more detrimental than the cancer. A study published today in JAMA Network Open by researchers ...
- C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series Bon April 15, 2021 at 7:00 am
If you or a loved one has ever undergone a tumor removal as part of cancer treatment, you’re likely familiar with the period of uncertainty and fear that follows. Will the cancer return, and if so, ...
- Urothelial Cancer Treatment Market to Showcase Attractive Growth Opportunities Worldwideon April 15, 2021 at 4:12 am
The urothelial cancer develops due to the abnormal growth of urothelium. Urothelial cancer is the most common type of bladder cancer. Urothelial cancer is divided into two types, Invasive and ...
via Bing News